ArticleMikrochimica acta2026
Fe/Mo-doped carbon dots as a bifunctional nanozyme for self-validating colorimetric and fluorometric sensing of hydroquinone.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bimetallic Fe/Mo-doped carbon dots (Fe/Mo-CDs) have been developed as a high-performance nanozyme to construct a self-validating dual-mode (colorimetric/fluorometric) platform for hydroquinone (HQ) detection. The Fe/Mo-CDs exhibited strong peroxidase-like activity, catalyzing H2O2-mediated TMB oxidation to generate oxTMB, which simultaneously yields a colorimetric signal and quenches the fluorescence of Fe/Mo-CDs through a confirmed FRET process. The introduction of HQ competitively scavenges the essential reactive oxygen species, inhibiting oxTMB formation and triggering synchronous signal inversion in both channels. This endogenous self-validating function enables favorable analytical performance, with wide linear ranges and ultralow detection limits (0.03 µM for colorimetric; 0.016 µM for fluorometric). Successful application in commercial creams with satisfactory recoveries underscores its strong potential for accurate and reliable screening in complex samples. This work not only presents a sensitive sensor for HQ but also offers a novel design strategy for developing intelligent, self-validating biosensing systems.
Indexed as
Identifiers
42032348What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.